Vimeo
LinkedIn
Instagram
Share |

Campden Wealth

July 6, 2022

Companies developing pioneering oesophageal drug-delivery systems, innovative bio-wearables and a venture builder for MedTech and biotech advances will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

Companies developing pioneering oesophageal drug-delivery systems, innovative bio-wearables and a venture builder for MedTech and biotech advances will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

June 21, 2022

The potential for uncorrelated, income-driven returns and structural inflation protection are two reasons why an allocation to unlisted infrastructure should be considered, says Michael Steingold of Russell Investments.

The potential for uncorrelated, income-driven returns and structural inflation protection are two reasons why an allocation to unlisted infrastructure should be considered [1]. However, there are several practical challenges facing investors to build and maintain a well-balanced, diversified infrastructure allocation that is appropriately positioned to harvest the benefits of the asset class.

June 16, 2022

In an exclusive interview with Campden FB, David G. Wilson talks about growing up in the family that created the James Bond movie franchise and how he’s pushing things forward into gaming, Web3, the metaverse and beyond – cementing his reputation as an astute custodian of the family wealth.

As the 'shirtsleeves-to-shirtsleeves curse’ would have it, 70% of ultra-high net worth families lose their fortune by the second generation, while an astonishing 90% squander it by the third generation. That’s a lot of hard-earned inherited wealth misplaced due to poor preparedness and lack of vision.

June 9, 2022

Companies developing complex disease-solving data curation, heart-failure telemonitoring and home sperm testing will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

Companies developing complex disease-solving data curation, heart-failure telemonitoringand home sperm testing will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

June 6, 2022

Investors continue to increase exposure to private markets, including private equity and private credit, at the expense of their public market equity and fixed income allocations. So, what is driving this behaviour asks Darren Spencer of Russell Investments?

Investor interest and participation in private markets continues to grow. Indeed, investors continue to increase exposure to private markets, including private equity and private credit, at the expense of their public market equity and fixed income allocations. In fact, CEM Benchmarking noted there was an average allocation to private markets of 18.5% in 2020, which represents an increase of nearly 5% since 2012 [1]. So, what is driving this investor behaviour?

April 4, 2022

The chairman of Campden Club’s two-day event on March 30 and 31 talks to Campden FB about his main takeaways.

The chairman of Campden Club’s two-day event on March 30 and 31 talks to Campden FB about his main takeaways.

Over two days at The Grand Hyatt Hotel in Berlin, members of ultra-high-net-worth financial families took part in a series of revelatory presentations and sessions in which the subject of legacy, pertaining to the three key pillars of purpose, people and profit, was discussed.

April 4, 2022

INSPIRA is developing a cost-effective respiratory support system which will function as an artificial lung for deteriorating respiratory patients. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and co-founder Joe Hayon explains the benefits and potential future applications of the system.

INSPIRA is an innovative medical device company which is developing the ART system, a cost-effective early extracorporeal respiratory support system which will function as an artificial lung for deteriorating respiratory patients.

The ART system utilises a new approach based on hemo-protective technology aimed at rebalancing oxygen saturation levels while patients are awake and breathing, potentially minimising the patient's need for invasive mechanical ventilation intervention.

March 24, 2022

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

March 21, 2022

Implementing a successful private markets program as part of a total portfolio is not without some implementation challenges, says Russell Investments’ alternative investments client portfolio manager Darren Spencer, and perhaps the most pressing issue investors face which needs to be solved for is managing the J-curve.

Click here >>
Close